This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Biomerieux, Inc.. Active years: 2002-2012.
Location History:
- Saint Foy les Lyon, FR (2002)
- Sainte Foy les Lynn, FR (2012)
Company Filing History:
Years Active: 2002-2012
Title: Odile Letourneur: Innovator in Rheumatoid Arthritis Detection
Introduction
Odile Letourneur is a notable inventor based in Sainte-Foy-lès-Lyon, France. He has made significant contributions to the field of medical diagnostics, particularly in the detection of rheumatoid arthritis. With a total of 2 patents to his name, Letourneur's work is recognized for its innovative approaches to complex medical challenges.
Latest Patents
Letourneur's latest patents include a method for detecting rheumatoid arthritis-specific autoantibodies. This method involves using a filaggrin with no citrulline residues, which is crucial for identifying anti-filaggrin-autoantibodies in biological samples. The process includes contacting the sample with specific filaggrin variants and quantifying the resulting immune complexes to determine the presence of these autoantibodies. Another significant patent focuses on HBc expression and its diagnostic and therapeutic uses. This patent describes a cassette that functions in yeast cells to control the expression of HBc Ag and its fragments, which is essential for monitoring HBV infections and developing vaccines.
Career Highlights
Odile Letourneur is currently associated with bioMérieux, Inc., a company renowned for its expertise in in vitro diagnostics. His work at bioMérieux has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in medical technology.
Collaborations
Letourneur has collaborated with notable colleagues, including Michel C Jolivet and Maria Léonor Nogueira. These collaborations have fostered a productive environment for research and development in the field of diagnostics.
Conclusion
Odile Letourneur's contributions to medical diagnostics, particularly in rheumatoid arthritis detection, highlight his innovative spirit and dedication to improving healthcare. His patents and work at bioMérieux reflect a commitment to advancing medical technology for better patient outcomes.